At 3-year follow-up , target-vessel failure did not differ between patients treated for bifurcation versus nonbifurcation lesions ( 13.1 % vs 12.6 % ; P = .84 ) , whereas the periprocedural myocardial infarction rate was higher in patients with bifurcation lesions ( 6.9 % vs 3.1 % ; P < .01 ) .